NIH-funded research U01 cooperative agreement

Real-time pharmacy alerts to help New Yorkers stay on HIV medicines

Official title: RFA-PS-21-004: Using Real-time Prescription Data to Support HIV Care and Treatment Adherence in NYC

Funded at Amida Care INC. · NIH-11422101 · Data updated 2026-11-12

This project uses real-time pharmacy data to find and help people with HIV in New York City who miss antiretroviral refills at 30 or 60 days.

More Treatment Adherence research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionAmida Care INC.
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 30, 2022
Project endSeptember 29, 2026
Funding year2025
Award (this year)$492,622
NIH project number6U01PS005221-04M001
Project IDNIH-11422101 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people with HIV in New York City who are enrolled with participating insurers or pharmacies and who miss ARV refills by about 30 or 60 days.

Less likely to help

People who live outside NYC, are not served by the participating pharmacy/insurance partners, or who already pick up refills reliably are unlikely to be reached or benefit from this project.

What this research studies

If you have HIV and live in New York City, this project watches pharmacy insurance claims to spot when someone misses an ARV refill by 30 or 60 days. Partner organizations — including a Medicaid plan, community groups, CUNY evaluators, and the state health department — will reach out and offer tailored supports like reminders, counseling, or help with appointments and transportation. The team links refill records with lab and visit data so they can act before a gap in care leads to worse health. The university partner will analyze the results to learn whether these real-time interventions help people stay on medications and keep viral loads suppressed.

Why it matters

Potential benefit: If successful, this approach could help more people stay on HIV medication, improve viral suppression, and reduce loss from care in NYC.

How similar studies have gone: Related Data-to-Care programs using surveillance or claims data have helped re-engage people with HIV before, though using near real-time pharmacy refill alerts at 30/60 days is a newer application.

Where this research is happening

  • Amida Care INC.
    New York, United States
    Active

Researchers

  • Principal investigator: Antonios, Vera — Amida Care INC.
  • Study coordinator: Antonios, Vera

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.